LINCOLN, Neb., Dec. 01, 2015 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRCIA) (NASDAQ:NRCIB) today announced that its Board of Directors has declared a special dividend of thirty-six cents ($0.36) per Class A share and two dollars and sixteen cents ($2.16) per Class B share of common stock to shareholders of record as of the close of business on Thursday, December 31, 2015, and payable on Friday, January 15, 2016.
In addition, a quarterly cash dividend of $0.08 (eight cents) per Class A share and $.48 (forty-eight cents) per Class B share will be payable Friday, January 15, 2016, to shareholders of record as of the close of business on Thursday, December 31, 2015.
For more than 34 years, National Research Corporation has been at the forefront of patient-centered care, helping healthcare providers measure and improve quality and services through analytics that offer a rich understanding of customers’ experiences, preferences, risks and behaviors across the healthcare continuum.
Contact: Kevin R. Karas Chief Financial Officer 402-475-2525


Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Apple Turns 50: From Garage Startup to AI Crossroads
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Bank of America's $72.5M Epstein Settlement: What You Need to Know 



